Literature DB >> 35275246

A novel auricular prosthesis which incorporates a cartilage conduction hearing aid based on 3D data processing technique: a preclinical evaluation.

Takanori Nishiyama1, Shintaro Hayashi2, Naoki Oishi3.   

Abstract

PURPOSE: To achieve the challenging goal of simultaneously improving aesthetics and auditory function in the treatment of microtia, we developed an auricular prosthesis incorporating a cartilage conduction hearing aid (APiCHA), which covers a cartilage conduction hearing aid (CC-HA). We evaluated the acoustic characteristics generated by the method of combining these two components using an artificial mastoid and investigated the possibility of clinical translation.
METHODS: The first step in creating an APiCHA is to take molds of both the affected and normal auricles and invert the 3D data of the normal auricle to create data for the auricular prostheses. Grooves were then made inside the prosthetic data to fit the affected ear and a CC-HA, and the APiCHA was made of silicone. The acoustic characteristics were measured using an artificial mastoid, and the results were compared between CC-HA alone and with APiCHA.
RESULTS: Compared with CC-HA alone, the gain was approximately 2 dB lower at high frequencies from 1 k Hz and higher, and approximately 2 dB higher at approximately 900 Hz when CC-HA was used with APiCHA. For the other frequencies, the acoustic characteristics were almost the same.
CONCLUSION: The changes in acoustic characteristics caused by the combined use of APiCHA and CC-HA were minimal and did not pose a clinical problem. The combined use of APiCHA and CC-HA can be considered as a non-invasive and clinically applicable treatment option to achieve both aesthetic and auditory improvements for microtia.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  3D data processing; Atresia; Atresiaplasty; Auricular reconstruction; Hearing loss; Microtia

Mesh:

Year:  2022        PMID: 35275246     DOI: 10.1007/s00405-022-07330-w

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  8 in total

1.  Cartilage Conduction Hearing Aids for Severe Conduction Hearing Loss.

Authors:  Tadashi Nishimura; Hiroshi Hosoi; Osamu Saito; Ryota Shimokura; Toshiaki Yamanaka; Tadashi Kitahara
Journal:  Otol Neurotol       Date:  2018-01       Impact factor: 2.311

2.  Long-term Hearing Outcome of Canaloplasty With Partial Ossicular Replacement in Congenital Aural Atresia.

Authors:  Jungmin Ahn; Gwanghui Ryu; Minwoong Kang; Yang-Sun Cho
Journal:  Otol Neurotol       Date:  2018-06       Impact factor: 2.311

3.  Efficacy of cartilage conduction hearing aids in children.

Authors:  Takanori Nishiyama; Naoki Oishi; Kaoru Ogawa
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2021-01-16       Impact factor: 1.675

4.  Assisted retention of a hearing device in an implant-retained auricular prosthesis.

Authors:  R M Taft; A S von Gonten; S T Wheeler
Journal:  J Prosthet Dent       Date:  2001-10       Impact factor: 3.426

5.  In-the-ear hearing aids within auricular prostheses.

Authors:  J J Homer; A C Roberts; C L Wengraf
Journal:  J Laryngol Otol       Date:  2001-12       Impact factor: 1.469

6.  Who are good adult candidates for cartilage conduction hearing aids?

Authors:  Takanori Nishiyama; Naoki Oishi; Kaoru Ogawa
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-08-06       Impact factor: 2.503

Review 7.  Atresiaplasty in Congenital Aural Atresia: What the Facial Plastic Surgeon Needs to Know.

Authors:  Douglas S Ruhl; Bradley W Kesser
Journal:  Facial Plast Surg Clin North Am       Date:  2018-02       Impact factor: 1.918

8.  Auricular prostheses attached to osseointegrated implants: multidisciplinary work-up and clinical evaluation.

Authors:  Maarten A Vijverberg; Luc Verhamme; Pascal van de Pol; Henricus P M Kunst; Emmanuel A M Mylanus; Myrthe K S Hol
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-02-05       Impact factor: 2.503

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.